Literature DB >> 28830890

Increased risk of leukemia among sickle cell disease patients in California.

Ann Brunson1, Theresa H M Keegan1, Heejung Bang2,3, Anjlee Mahajan1, Susan Paulukonis4, Ted Wun1,3,5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28830890      PMCID： PMC5620417          DOI： 10.1182/blood-2017-05-783233

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea.

Authors:  S Wilson
Journal:  Ann Intern Med       Date:  2000-12-05       Impact factor: 25.391

2.  Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.

Authors:  Olena O Seminog; Oyindamola I Ogunlaja; David Yeates; Michael J Goldacre
Journal:  J R Soc Med       Date:  2016-06-20       Impact factor: 5.344

Review 3.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

4.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

Review 5.  Emerging avenues linking inflammation and cancer.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Free Radic Biol Med       Date:  2012-03-03       Impact factor: 7.376

6.  Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.

Authors:  Susan T Paulukonis; James R Eckman; Angela B Snyder; Ward Hagar; Lisa B Feuchtbaum; Mei Zhou; Althea M Grant; Mary M Hulihan
Journal:  Public Health Rep       Date:  2016 Mar-Apr       Impact factor: 2.792

7.  Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.

Authors:  Leo R Zacharski; Bruce K Chow; Paula S Howes; Galina Shamayeva; John A Baron; Ronald L Dalman; David J Malenka; C Keith Ozaki; Philip W Lavori
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506

8.  Hematologic malignancy in sickle cell disease: report of four cases and review of the literature.

Authors:  R B Stricker; C A Linker; T J Crowley; S H Embury
Journal:  Am J Hematol       Date:  1986-02       Impact factor: 10.047

Review 9.  Inflammation and cancer: advances and new agents.

Authors:  Shanthini M Crusz; Frances R Balkwill
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

10.  Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.

Authors:  David S Terman; Benjamin L Viglianti; Rahima Zennadi; Diane Fels; Richard J Boruta; Hong Yuan; Mathew R Dreher; Gerald Grant; Zahid N Rabbani; Ejung Moon; Lan Lan; Joseph Eble; Yiting Cao; Brian Sorg; Kathleen Ashcraft; Greg Palmer; Marilyn J Telen; Mark W Dewhirst
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240
View more
  29 in total

1.  Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation.

Authors:  Jack Y Ghannam; Xin Xu; Irina Maric; Laura Dillon; Yuesheng Li; Matthew M Hsieh; Christopher S Hourigan; Courtney D Fitzhugh
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

2.  Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.

Authors:  Matthew M Hsieh; Melissa Bonner; Francis John Pierciey; Naoya Uchida; James Rottman; Laura Demopoulos; Manfred Schmidt; Julie Kanter; Mark C Walters; Alexis A Thompson; Mohammed Asmal; John F Tisdale
Journal:  Blood Adv       Date:  2020-05-12

3.  Bleeding in patients with sickle cell disease: a population-based study.

Authors:  Nisha Hariharan; Ann Brunson; Anjlee Mahajan; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2020-03-10

4.  High incidence of venous thromboembolism recurrence in patients with sickle cell disease.

Authors:  Ann Brunson; Theresa Keegan; Anjlee Mahajan; Richard White; Ted Wun
Journal:  Am J Hematol       Date:  2019-06-12       Impact factor: 10.047

Review 5.  Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.

Authors:  Tolulope O Rosanwo; Daniel E Bauer
Journal:  Mol Ther       Date:  2021-10-08       Impact factor: 11.454

Review 6.  The transformative potential of HSC gene therapy as a genetic medicine.

Authors:  Pervinder Sagoo; H Bobby Gaspar
Journal:  Gene Ther       Date:  2021-05-26       Impact factor: 5.250

7.  Cancer specific survival in patients with sickle cell disease.

Authors:  Ann Brunson; Theresa H M Keegan; Anjlee Mahajan; Susan Paulukonis; Ted Wun
Journal:  Br J Haematol       Date:  2018-11-22       Impact factor: 6.998

8.  A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease.

Authors:  Alexis Leonard; John F Tisdale
Journal:  Mol Ther       Date:  2021-03-19       Impact factor: 11.454

Review 9.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

10.  Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases.

Authors:  Justine M Kahn; Ruta Brazauskas; Heather R Tecca; Stephanie Bo-Subait; David Buchbinder; Minoo Battiwala; Mary E D Flowers; Bipin N Savani; Rachel Phelan; Larisa Broglie; Allistair A Abraham; Amy K Keating; Andrew Daly; Baldeep Wirk; Biju George; Blanche P Alter; Celalettin Ustun; Cesar O Freytes; Amer M Beitinjaneh; Christine Duncan; Edward Copelan; Gerhard C Hildebrandt; Hemant S Murthy; Hillard M Lazarus; Jeffery J Auletta; Kasiani C Myers; Kirsten M Williams; Kristin M Page; Lynda M Vrooman; Maxim Norkin; Michael Byrne; Miguel Angel Diaz; Naynesh Kamani; Neel S Bhatt; Andrew Rezvani; Nosha Farhadfar; Parinda A Mehta; Peiman Hematti; Peter J Shaw; Rammurti T Kamble; Raquel Schears; Richard F Olsson; Robert J Hayashi; Robert Peter Gale; Samantha J Mayo; Saurabh Chhabra; Seth J Rotz; Sherif M Badawy; Siddhartha Ganguly; Steven Pavletic; Taiga Nishihori; Tim Prestidge; Vaibhav Agrawal; William J Hogan; Yoshihiro Inamoto; Bronwen E Shaw; Prakash Satwani
Journal:  Blood Adv       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.